Skip to main content

DIADEMA PARTNERS LP

Position in PCVX — Vaxcyte, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,619,977
+$1,163,102 QoQ
Shares Held
45,071
+79.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#121
of 329 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Derivatives in PCVX

reported options exposure · as of Jun 30, 2026
CallValue
$3,086,703
CallShares
53,100
PutValue
$2,842,557
PutShares
48,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names. PCVX ranks #19 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,086,703 53,100
2026-06-30 $2,842,557 48,900
2026-06-30 $2,619,977 45,071
2026-03-31 $3,085,641 53,100
2026-03-31 $1,456,875 25,071
2025-12-31 $1,059,928 22,972
2025-09-30 $7,862,625 218,285
2025-06-30 $6,446,245 198,285
2025-03-31 $1,948,416 51,600
2025-03-31 $3,488,457 92,385
2024-12-31 $818,600 10,000